PDB Short entry for 1TMQ HEADER HYDROLASE/HYDROLASE INHIBITOR 13-JAN-98 1TMQ TITLE STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE IN COMPLEX WITH TITLE 2 RAGI BIFUNCTIONAL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (ALPHA-AMYLASE); COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.1; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROTEIN (RAGI BIFUNCTIONAL INHIBITOR); COMPND 7 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TENEBRIO MOLITOR; SOURCE 3 ORGANISM_COMMON: YELLOW MEALWORM; SOURCE 4 ORGANISM_TAXID: 7067; SOURCE 5 TISSUE: LARVAE; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: ELEUSINE CORACANA; SOURCE 8 ORGANISM_COMMON: FINGER MILLET; SOURCE 9 ORGANISM_TAXID: 4511; SOURCE 10 ORGAN: SEED KEYWDS ALPHA-AMYLASE, CARBOHYDRATE METABOLISM, ALPHA-1, 4-GLUCAN-4- KEYWDS 2 GLUCANOHYDROLASE, HYDROLASE BIFUNCTIONAL ALPHA-AMYLASE/TRYPSIN KEYWDS 3 INHIBITOR, COMPLEX (ENZYME- INHIBITOR), HYDROLASE-HYDROLASE KEYWDS 4 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.X.GOMIS-RUETH,S.STROBL,R.GLOCKSHUBER REVDAT 6 23-AUG-23 1TMQ 1 REMARK REVDAT 5 25-DEC-19 1TMQ 1 SEQADV SEQRES REVDAT 4 20-NOV-19 1TMQ 1 SEQADV LINK REVDAT 3 24-FEB-09 1TMQ 1 VERSN REVDAT 2 29-DEC-99 1TMQ 4 HEADER COMPND REMARK JRNL REVDAT 2 2 4 ATOM SOURCE SEQRES REVDAT 1 02-MAR-99 1TMQ 0 JRNL AUTH S.STROBL,K.MASKOS,G.WIEGAND,R.HUBER,F.X.GOMIS-RUTH, JRNL AUTH 2 R.GLOCKSHUBER JRNL TITL A NOVEL STRATEGY FOR INHIBITION OF ALPHA-AMYLASES: YELLOW JRNL TITL 2 MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE RAGI JRNL TITL 3 BIFUNCTIONAL INHIBITOR AT 2.5 A RESOLUTION. JRNL REF STRUCTURE V. 6 911 1998 JRNL REFN ISSN 0969-2126 JRNL PMID 9687373 JRNL DOI 10.1016/S0969-2126(98)00092-6 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.STROBL,F.X.GOMIS-RUTH,K.MASKOS,G.FRANK,R.HUBER, REMARK 1 AUTH 2 R.GLOCKSHUBER REMARK 1 TITL THE ALPHA-AMYLASE FROM THE YELLOW MEAL WORM: COMPLETE REMARK 1 TITL 2 PRIMARY STRUCTURE, CRYSTALLIZATION AND PRELIMINARY X-RAY REMARK 1 TITL 3 ANALYSIS REMARK 1 REF FEBS LETT. V. 409 109 1997 REMARK 1 REFN ISSN 0014-5793 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26825 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R FACTOR REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4487 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 331 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TMQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000008384. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM V. 5.30, CCP4 REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28178 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.28400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1BIP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200MM AMMONIUM PHOSPHATE, 100MM TRIS REMARK 280 -HCL, PH 8.5, 50% (W/V) 2-METHYL-2,4- PENTANEDIOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.77000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.77000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.58000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 93.43500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.58000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 93.43500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.77000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.58000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 93.43500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.77000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.58000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 93.43500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE ALPHA-AMYLASE N-TERMINUS BLOCKS AGAINST REMARK 400 AMINOPEPTIDASE ACTIVITY BY GLUTAMINE CYCLIZATION TO RENDER REMARK 400 PYROGLUTAMATE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 121 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 12 143.89 76.12 REMARK 500 PHE A 31 -50.02 -135.34 REMARK 500 ASN A 68 101.96 -167.95 REMARK 500 MET A 100 -123.91 -116.72 REMARK 500 ASN A 137 3.98 -151.82 REMARK 500 ASN A 266 32.69 -97.00 REMARK 500 ASP A 350 -75.22 -5.32 REMARK 500 ASP A 351 32.39 -73.97 REMARK 500 ASN A 352 22.11 47.42 REMARK 500 ASP A 390 -113.54 -165.45 REMARK 500 VAL B 502 -94.12 65.12 REMARK 500 MET B 510 -109.30 -127.22 REMARK 500 MET B 564 -72.23 -68.56 REMARK 500 LEU B 579 68.26 -69.14 REMARK 500 GLU B 602 -112.00 -96.51 REMARK 500 LEU B 615 -174.56 -66.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1001 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 98 OD1 REMARK 620 2 ARG A 146 O 154.8 REMARK 620 3 ASP A 155 OD1 79.7 109.9 REMARK 620 4 ASP A 155 OD2 118.5 83.4 50.0 REMARK 620 5 HIS A 189 O 76.6 81.3 138.0 164.7 REMARK 620 6 HOH A1049 O 97.9 68.0 64.1 90.1 85.3 REMARK 620 7 HOH A5011 O 107.1 82.2 136.8 93.1 83.7 149.5 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1001 DBREF 1TMQ A 1 471 UNP P56634 AMY_TENMO 2 471 DBREF 1TMQ B 501 617 UNP P01087 IAAT_ELECO 1 117 SEQADV 1TMQ SER B 570 UNP P01087 PRO 70 CONFLICT SEQRES 1 A 471 PCA LYS ASP ALA ASN PHE ALA SER GLY ARG ASN SER ILE SEQRES 2 A 471 VAL HIS LEU PHE GLU TRP LYS TRP ASN ASP ILE ALA ASP SEQRES 3 A 471 GLU CYS GLU ARG PHE LEU GLN PRO GLN GLY PHE GLY GLY SEQRES 4 A 471 VAL GLN ILE SER PRO PRO ASN GLU TYR LEU VAL ALA ASP SEQRES 5 A 471 GLY ARG PRO TRP TRP GLU ARG TYR GLN PRO VAL SER TYR SEQRES 6 A 471 ILE ILE ASN THR ARG SER GLY ASP GLU SER ALA PHE THR SEQRES 7 A 471 ASP MET THR ARG ARG CYS ASN ASP ALA GLY VAL ARG ILE SEQRES 8 A 471 TYR VAL ASP ALA VAL ILE ASN HIS MET THR GLY MET ASN SEQRES 9 A 471 GLY VAL GLY THR SER GLY SER SER ALA ASP HIS ASP GLY SEQRES 10 A 471 MET ASN TYR PRO ALA VAL PRO TYR GLY SER GLY ASP PHE SEQRES 11 A 471 HIS SER PRO CYS GLU VAL ASN ASN TYR GLN ASP ALA ASP SEQRES 12 A 471 ASN VAL ARG ASN CYS GLU LEU VAL GLY LEU ARG ASP LEU SEQRES 13 A 471 ASN GLN GLY SER ASP TYR VAL ARG GLY VAL LEU ILE ASP SEQRES 14 A 471 TYR MET ASN HIS MET ILE ASP LEU GLY VAL ALA GLY PHE SEQRES 15 A 471 ARG VAL ASP ALA ALA LYS HIS MET SER PRO GLY ASP LEU SEQRES 16 A 471 SER VAL ILE PHE SER GLY LEU LYS ASN LEU ASN THR ASP SEQRES 17 A 471 TYR GLY PHE ALA ASP GLY ALA ARG PRO PHE ILE TYR GLN SEQRES 18 A 471 GLU VAL ILE ASP LEU GLY GLY GLU ALA ILE SER LYS ASN SEQRES 19 A 471 GLU TYR THR GLY PHE GLY CYS VAL LEU GLU PHE GLN PHE SEQRES 20 A 471 GLY VAL SER LEU GLY ASN ALA PHE GLN GLY GLY ASN GLN SEQRES 21 A 471 LEU LYS ASN LEU ALA ASN TRP GLY PRO GLU TRP GLY LEU SEQRES 22 A 471 LEU GLU GLY LEU ASP ALA VAL VAL PHE VAL ASP ASN HIS SEQRES 23 A 471 ASP ASN GLN ARG THR GLY GLY SER GLN ILE LEU THR TYR SEQRES 24 A 471 LYS ASN PRO LYS PRO TYR LYS MET ALA ILE ALA PHE MET SEQRES 25 A 471 LEU ALA HIS PRO TYR GLY THR THR ARG ILE MET SER SER SEQRES 26 A 471 PHE ASP PHE THR ASP ASN ASP GLN GLY PRO PRO GLN ASP SEQRES 27 A 471 GLY SER GLY ASN LEU ILE SER PRO GLY ILE ASN ASP ASP SEQRES 28 A 471 ASN THR CYS SER ASN GLY TYR VAL CYS GLU HIS ARG TRP SEQRES 29 A 471 ARG GLN VAL TYR GLY MET VAL GLY PHE ARG ASN ALA VAL SEQRES 30 A 471 GLU GLY THR GLN VAL GLU ASN TRP TRP SER ASN ASP ASP SEQRES 31 A 471 ASN GLN ILE ALA PHE SER ARG GLY SER GLN GLY PHE VAL SEQRES 32 A 471 ALA PHE THR ASN GLY GLY ASP LEU ASN GLN ASN LEU ASN SEQRES 33 A 471 THR GLY LEU PRO ALA GLY THR TYR CYS ASP VAL ILE SER SEQRES 34 A 471 GLY GLU LEU SER GLY GLY SER CYS THR GLY LYS SER VAL SEQRES 35 A 471 THR VAL GLY ASP ASN GLY SER ALA ASP ILE SER LEU GLY SEQRES 36 A 471 SER ALA GLU ASP ASP GLY VAL LEU ALA ILE HIS VAL ASN SEQRES 37 A 471 ALA LYS LEU SEQRES 1 B 117 SER VAL GLY THR SER CYS ILE PRO GLY MET ALA ILE PRO SEQRES 2 B 117 HIS ASN PRO LEU ASP SER CYS ARG TRP TYR VAL SER THR SEQRES 3 B 117 ARG THR CYS GLY VAL GLY PRO ARG LEU ALA THR GLN GLU SEQRES 4 B 117 MET LYS ALA ARG CYS CYS ARG GLN LEU GLU ALA ILE PRO SEQRES 5 B 117 ALA TYR CYS ARG CYS GLU ALA VAL ARG ILE LEU MET ASP SEQRES 6 B 117 GLY VAL VAL THR SER SER GLY GLN HIS GLU GLY ARG LEU SEQRES 7 B 117 LEU GLN ASP LEU PRO GLY CYS PRO ARG GLN VAL GLN ARG SEQRES 8 B 117 ALA PHE ALA PRO LYS LEU VAL THR GLU VAL GLU CYS ASN SEQRES 9 B 117 LEU ALA THR ILE HIS GLY GLY PRO PHE CYS LEU SER LEU MODRES 1TMQ PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET CL A1002 1 HET CA A1001 1 HETNAM PCA PYROGLUTAMIC ACID HETNAM CL CHLORIDE ION HETNAM CA CALCIUM ION FORMUL 1 PCA C5 H7 N O3 FORMUL 3 CL CL 1- FORMUL 4 CA CA 2+ FORMUL 5 HOH *331(H2 O) HELIX 1 1 TRP A 21 ARG A 30 1 10 HELIX 2 2 TRP A 56 TYR A 60 5 5 HELIX 3 3 GLU A 74 ASP A 86 1 13 HELIX 4 4 SER A 127 ASP A 129 5 3 HELIX 5 5 ALA A 142 ASN A 147 1 6 HELIX 6 6 ASP A 161 ASP A 176 1 16 HELIX 7 7 ALA A 187 HIS A 189 5 3 HELIX 8 8 PRO A 192 GLY A 201 1 10 HELIX 9 9 THR A 207 TYR A 209 5 3 HELIX 10 10 LYS A 233 GLU A 235 5 3 HELIX 11 11 PHE A 245 GLN A 256 1 12 HELIX 12 12 LEU A 261 ASN A 266 5 6 HELIX 13 13 PRO A 269 TRP A 271 5 3 HELIX 14 14 GLY A 276 ASP A 278 5 3 HELIX 15 15 ASN A 288 THR A 291 1 4 HELIX 16 16 TYR A 299 ALA A 314 5 16 HELIX 17 17 GLU A 361 ARG A 363 5 3 HELIX 18 18 ARG A 365 ALA A 376 1 12 HELIX 19 19 VAL B 502 SER B 505 5 4 HELIX 20 20 ASP B 518 CYS B 529 5 12 HELIX 21 21 THR B 537 GLU B 549 1 13 HELIX 22 22 ALA B 553 ASP B 565 1 13 HELIX 23 23 ARG B 587 VAL B 598 1 12 SHEET 1 A 6 ARG A 321 SER A 324 0 SHEET 2 A 6 ILE A 13 LEU A 16 1 N ILE A 13 O ILE A 322 SHEET 3 A 6 GLY A 39 GLN A 41 1 N GLY A 39 O VAL A 14 SHEET 4 A 6 ARG A 90 ALA A 95 1 N ARG A 90 O VAL A 40 SHEET 5 A 6 GLY A 181 VAL A 184 1 N GLY A 181 O VAL A 93 SHEET 6 A 6 PHE A 218 GLN A 221 1 N PHE A 218 O PHE A 182 SHEET 1 B 2 GLY A 347 ASN A 349 0 SHEET 2 B 2 THR A 353 SER A 355 -1 N SER A 355 O GLY A 347 SHEET 1 C 3 GLN A 392 SER A 396 0 SHEET 2 C 3 GLY A 401 THR A 406 -1 N PHE A 405 O ILE A 393 SHEET 3 C 3 VAL A 462 HIS A 466 -1 N ILE A 465 O PHE A 402 SHEET 1 D 2 LEU A 411 ASN A 416 0 SHEET 2 D 2 SER A 449 LEU A 454 -1 N LEU A 454 O LEU A 411 SHEET 1 E 2 GLY A 422 CYS A 425 0 SHEET 2 E 2 SER A 441 VAL A 444 -1 N VAL A 444 O GLY A 422 SSBOND 1 CYS A 28 CYS A 84 1555 1555 2.03 SSBOND 2 CYS A 134 CYS A 148 1555 1555 2.03 SSBOND 3 CYS A 354 CYS A 360 1555 1555 2.02 SSBOND 4 CYS A 425 CYS A 437 1555 1555 2.02 SSBOND 5 CYS B 506 CYS B 555 1555 1555 2.03 SSBOND 6 CYS B 520 CYS B 544 1555 1555 2.04 SSBOND 7 CYS B 529 CYS B 585 1555 1555 2.03 SSBOND 8 CYS B 545 CYS B 603 1555 1555 2.02 SSBOND 9 CYS B 557 CYS B 614 1555 1555 2.03 LINK C PCA A 1 N LYS A 2 1555 1555 1.32 LINK OD1 ASN A 98 CA CA A1001 1555 1555 2.42 LINK O ARG A 146 CA CA A1001 1555 1555 2.28 LINK OD1 ASP A 155 CA CA A1001 1555 1555 2.67 LINK OD2 ASP A 155 CA CA A1001 1555 1555 2.46 LINK O HIS A 189 CA CA A1001 1555 1555 2.40 LINK CA CA A1001 O HOH A1049 1555 1555 2.57 LINK CA CA A1001 O HOH A5011 1555 1555 2.09 CISPEP 1 VAL A 123 PRO A 124 0 -0.93 SITE 1 AC1 5 ARG A 183 LEU A 243 ASN A 285 ARG A 321 SITE 2 AC1 5 HOH A1067 SITE 1 AC2 6 ASN A 98 ARG A 146 ASP A 155 HIS A 189 SITE 2 AC2 6 HOH A1049 HOH A5011 CRYST1 79.160 186.870 111.540 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012633 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005351 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008965 0.00000 HETATM 1 N PCA A 1 51.218 83.063 117.537 1.00 38.46 N HETATM 2 CA PCA A 1 52.443 82.320 117.226 1.00 34.67 C HETATM 3 CB PCA A 1 53.186 82.084 118.547 1.00 35.89 C HETATM 4 CG PCA A 1 52.767 83.399 119.333 1.00 39.67 C HETATM 5 CD PCA A 1 51.404 83.661 118.706 1.00 42.50 C HETATM 6 OE PCA A 1 50.524 84.376 119.249 1.00 46.89 O HETATM 7 C PCA A 1 52.323 81.099 116.342 1.00 30.36 C HETATM 8 O PCA A 1 51.335 80.356 116.347 1.00 27.13 O